Morepen Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
For the full year, sales was INR 14,175.3 million compared to INR 15,468.27 million a year ago. Revenue was INR 14,236.63 million compared to INR 15,571.34 million a year ago. Net income was INR 386.75 million compared to INR 1,016.83 million a year ago. Basic earnings per share from continuing operations was INR 0.77 compared to INR 2.26 a year ago. Diluted earnings per share from continuing operations was INR 0.77 compared to INR 1.96 a year ago.